AU2816195A - Synergistic antibiotic compositions containing a perphyrin and an antibiotic - Google Patents

Synergistic antibiotic compositions containing a perphyrin and an antibiotic

Info

Publication number
AU2816195A
AU2816195A AU28161/95A AU2816195A AU2816195A AU 2816195 A AU2816195 A AU 2816195A AU 28161/95 A AU28161/95 A AU 28161/95A AU 2816195 A AU2816195 A AU 2816195A AU 2816195 A AU2816195 A AU 2816195A
Authority
AU
Australia
Prior art keywords
antibiotic
perphyrin
compositions containing
synergistic
antibiotic compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28161/95A
Inventor
Zvi Malik
Yeshayahu Nitzan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bar Ilan University
Original Assignee
Bar Ilan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL10987594A external-priority patent/IL109875A0/en
Priority claimed from IL10987694A external-priority patent/IL109876A0/en
Priority claimed from IL10987494A external-priority patent/IL109874A0/en
Application filed by Bar Ilan University filed Critical Bar Ilan University
Publication of AU2816195A publication Critical patent/AU2816195A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AU28161/95A 1994-06-02 1995-05-30 Synergistic antibiotic compositions containing a perphyrin and an antibiotic Abandoned AU2816195A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
IL109875 1994-06-02
IL10987594A IL109875A0 (en) 1994-06-02 1994-06-02 Antimicrobial cream compositions
IL109876 1994-06-02
IL109874 1994-06-02
IL10987694A IL109876A0 (en) 1994-06-02 1994-06-02 Antimicrobial liquid compositions
IL10987494A IL109874A0 (en) 1994-06-02 1994-06-02 Synergistic antimicrobial compositions
PCT/US1995/006998 WO1995033463A2 (en) 1994-06-02 1995-05-30 Synergistic antibiotic compositions containing a perphyrin and an antibiotic

Publications (1)

Publication Number Publication Date
AU2816195A true AU2816195A (en) 1996-01-04

Family

ID=27271659

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28161/95A Abandoned AU2816195A (en) 1994-06-02 1995-05-30 Synergistic antibiotic compositions containing a perphyrin and an antibiotic

Country Status (5)

Country Link
EP (1) EP0765161A2 (en)
AU (1) AU2816195A (en)
CA (1) CA2191627A1 (en)
NO (1) NO965109D0 (en)
WO (1) WO1995033463A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620805B1 (en) 1996-03-14 2003-09-16 Yale University Delivery of nucleic acids by porphyrins
NL1020336C2 (en) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Use of a compound for the preparation of a pharmaceutical preparation for treating burns, and a method for treating burns.
GB2397067B (en) 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
CN113425850B (en) * 2021-06-04 2022-10-11 江南大学 Photosensitive antibacterial modified porphyrin metal organic framework material and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU721442A1 (en) * 1977-09-12 1980-03-15 Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им. М.В. Ломоносова Method of preparing beta-unsubstituted porphyrins
JPS58981A (en) * 1981-06-26 1983-01-06 Tama Seikagaku Kk Water-soluble porphyrin derivative
US4753958A (en) * 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
JPS61189284A (en) * 1985-02-18 1986-08-22 Tama Seikagaku Kk Water-soluble porphyrin derivative metal chelate compound
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis
US5109016A (en) * 1988-05-23 1992-04-28 Georgia State University Foundation, Inc. Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
FR2683724A1 (en) * 1991-11-15 1993-05-21 Agronomique Inst Nat Rech BACTERICIDE PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND FOOD ADDITIVE.
JP4564596B2 (en) * 1992-04-30 2010-10-20 ユーシーエル ビジネス ピーエルシー Laser treatment
AU1296795A (en) * 1993-12-28 1995-07-17 New York Blood Center, Inc., The Methods for preventing or treating hiv-1 or hiv-2 infection

Also Published As

Publication number Publication date
WO1995033463A2 (en) 1995-12-14
EP0765161A2 (en) 1997-04-02
NO965109D0 (en) 1996-11-29
CA2191627A1 (en) 1995-12-14
WO1995033463A3 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
AU2616695A (en) Synergistic composition
AU7564694A (en) Erection-inducing methods and compositions
AU7323294A (en) Perfluoroelastomeric compositions and methods
AU1219795A (en) Anti-smoke perfumes and compositions
AU7842794A (en) Oral compositions
AU7446194A (en) 4-arylamino-benzopyran and related compounds
AU1678995A (en) Synergistic antifungal protein and compositions containing same
AU6276594A (en) Synergistic pesticidal compositions
AU3308195A (en) Antihypertriglyceridemic composition
AU6776494A (en) Oral compositions
AU1290597A (en) Synergistic bactericide
AU7437094A (en) Disinfectant-detergent composition
AU4425696A (en) Polymerizable compounds and compositions
AU6995594A (en) Aryltriflates and related compounds
AU7367894A (en) Methods and compositions incorporating ip-10
AU5520198A (en) Compositions containing lipophilic oligosaccharide antibiotic and albumin
AU5773994A (en) Cable-making compositions
AU7345094A (en) Oral compositions
AU4919597A (en) Synergistic composition comprising rapamycin and calcitriol
AU3806595A (en) Benzisoxazole derivatives and pesticidal compositions containing them
EP0760206A3 (en) Synergistic antimicrobial composition
AU2816195A (en) Synergistic antibiotic compositions containing a perphyrin and an antibiotic
AU4314393A (en) Synergistic biocide-agent combinations
AU672124B2 (en) Composition
AU5512694A (en) Oral composition